Durable response using regorafenib in an elderly patient with metastatic colorectal cancer: case report
Ronald Tang,1 Tatiana Kain,2 June Herman,2 Tara Seery1 1Division of Hematology-Oncology, 2Division of Nuclear Medicine and Molecular Imaging, University of California, Irvine, Orange, CA, USA Abstract: Regorafenib, an oral multikinase inhibitor, was approved in September 2012 by the US Food and Dru...
সংরক্ষণ করুন:
| প্রধান লেখক: | , , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
Dove Medical Press
2015-11-01
|
| মালা: | Cancer Management and Research |
| অনলাইন ব্যবহার করুন: | https://www.dovepress.com/durable-response-using-regorafenib-in-an-elderly-patient-with-metastat-peer-reviewed-article-CMAR |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|